-+ 0.00%
-+ 0.00%
-+ 0.00%

Bojian Marin will acquire Amicus Therapeutics at a cash price of $14.50 per share.

智通財經·12/19/2025 12:49:13
語音播報
Bojian Marin will acquire Amicus Therapeutics at a cash price of $14.50 per share.